TYPHOID VACCINE LIVE ATTENUATED (VIVOTIF)

Course overview

Typhoid vaccine live attenuated (TVL) is U.S. FDA-approved to immunize against disease caused by Salmonella typhi (typhoid fever) in persons ≥ 6 years. It must be used cautiously in acute gastrointestinal illness, or persistent vomiting or diarrhea. This continuing education module is designed to give the reader/learner an increased understanding of TVL. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.